“Drugmakers including Bristol-Myers Squibb Co., Pfizer Inc. (PFE) and Eli Lilly & Co. (LLY) have spent billions of dollars on ineffective therapies in a so-far fruitless effort to come up with a treatment for dementia and Alzheimer’s. Now, in the latest of a steady drumbeat of research that suggests diet, exercise and socializing remain patients’ best hope, a study published today in the Proceedings of the National Academy of Sciences shows that vitamins B6 and B12 combined with folic acid slowed atrophy of gray matter in brain areas affected by Alzheimer’s disease.”
Related posts:
China National Nuclear to Raise $2.6 Billion in IPO
Nebraska school district wants deaf child to change how he signs his name
Schoolboys told to imagine themselves as future prime minister justifying martial law
Brazil confirms investigation into reports of NSA spying
Trump says it will be hard to unify country without a ‘major event’
France bans controversial chemical BPA in food packaging
Fund Managers Are Ditching Wall Street for Florida's 0% State Income Tax
British Virgin Islands to comply with US tax evasion law
U.S. immigration forms project digitizes one form, at cost of $1 billion
John Paulson: Rationale for owning gold is valid
Charlotte police kill man running to them for help
Talk of CIA prisons censored at Guantanamo hearing
Obama's drone war a 'recruitment tool' for Isis: US air force whistleblowers
CIA Files Prove America Helped Saddam as He Gassed Iran
Scientists plan to launch thousands of GM 'Frankenflies' into fields